Advertisement

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Varsha Gandhi, PhD, on Ibrutinib

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Advertisement

Advertisement




Apr
16
Today In Oncology
Is Standard of Care Optimal for the Individual Patient?
LuPSMA-617 and Pembrolizumab in mCRPC
ASH-ISTH Create Guidelines for Pediatric VTE Prophylaxis
Asbestos-Free Talc Not Associated With Increased Risk for Respiratory Cancers
New Molecular-Based Model for Classification and Risk in Chronic Myelomonocytic Leukemia
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo